Imbio PHA (4.0.0) vs Rapid Aortic Measurements
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Imbio PHA focuses on assessing right ventricular dilation and related cardiac structures from CTPA scans to aid in diagnosing and risk stratifying pulmonary embolism and hypertension. In contrast, Rapid Aortic Measurements specializes in comprehensive, automated analysis and longitudinal tracking of aortic structures from various CT scans for the acute assessment and management of aortic disease. While both utilize AI for cardiovascular CT analysis, their primary clinical applications and specific measurement focuses are distinct.
Choose Imbio PHA (4.0.0) if…
Choose Imbio PHA (4.0.0) if your primary focus is the rapid, automated assessment of right ventricular dilation from CT pulmonary angiogram (CTPA) scans. This tool is specifically designed to aid in the diagnosis and risk stratification of pulmonary embolism and hypertension by providing key cardiac structure measurements like RV/LV and PA/Ao ratios.
View Imbio PHA (4.0.0) →Choose Rapid Aortic Measurements if…
Choose Rapid Aortic Measurements if you require comprehensive, automated analysis and longitudinal management of various aortic diseases from all types of CT scans. This tool excels in providing 24 guideline-based aortic measurements, detailed 3D reconstructions, and tracking anatomical changes over time for acute assessment and ongoing patient surveillance.
View Rapid Aortic Measurements →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Imbio PHA (4.0.0) | Rapid Aortic Measurements |
|---|---|---|
| Pricing | Unknown | Contact for pricing |
| Deployment | Cloud (AWS) or On-premise (VMware) or via partners (Nuance, Aidoc, Siemens Syngo.via, TeraRecon, FerrumHealth, Flywheel). | Cloud, On-premise, Hybrid |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Yes AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Imbio PHA (4.0.0) | Rapid Aortic Measurements |
|---|---|---|
| Name | Imbio PHA (4.0.0) | Rapid Aortic Measurements |
| Company | Imbio | iSchemaView |
| Description | Imbio PHA (4.0.0) is an FDA-cleared AI-powered medical image processing software that automatically measures cardiac structures from CT pulmonary angiogram (CTPA) scans to assess potential right ventricular dilation and aid in the diagnosis and risk stratification of pulmonary embolism and hypertension. | Rapid Aortic Measurements by iSchemaView (RapidAI) is an FDA-cleared AI-powered software for automated, accurate measurement and 3D reconstruction of aortic structures from CT scans, aiding in the acute assessment and longitudinal management of aortic disease. |
| Primary Focus | Cardiac structures from CT pulmonary angiogram (CTPA) scans for right ventricular dilation, pulmonary embolism, and hypertension. | Aortic structures from CT scans for aortic disease and patient surveillance. |
| Key Measurements/Features | Automated measurement of right and left ventricle diameters; Automated measurement of main pulmonary artery and aorta diameters; Calculates RV/LV and PA/Ao ratios; Generates annotated DICOM images; Provides summary reports in PDF format. | Rapid and accurate measurement of aortic structures; 24 automated guideline-based aortic measurements (6 zonal maximums, 18 landmark metrics); Automated 3D image reconstructions of the entire aorta; Longitudinal tracking and comparison of anatomical changes over time. |
Videos
Demos, reviews, and walkthroughs featuring Imbio PHA (4.0.0) and Rapid Aortic Measurements.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
Imbio PHA (4.0.0) is designed to assess potential right ventricular dilation from CT pulmonary angiogram (CTPA) scans, aiding in the diagnosis and risk stratification of pulmonary embolism and hypertension. Rapid Aortic Measurements by iSchemaView (RapidAI) focuses on the acute assessment and longitudinal management of aortic disease using automated measurements and 3D reconstruction of aortic structures from CT scans.
Imbio PHA (4.0.0) automatically measures right and left ventricle diameters, and main pulmonary artery and aorta diameters, then calculates RV/LV and PA/Ao ratios. Rapid Aortic Measurements provides 24 automated guideline-based aortic measurements, including 6 zonal maximums and 18 landmark metrics, along with 3D image reconstructions of the entire aorta.
Imbio PHA (4.0.0) specifically utilizes CT pulmonary angiogram (CTPA) scans for its analysis. Rapid Aortic Measurements can analyze all CT scans, including post-treatment and non-contrast studies, for aortic analysis.
Rapid Aortic Measurements explicitly offers longitudinal tracking and comparison of anatomical changes over time for aortic disease management. Imbio PHA (4.0.0)'s description does not mention longitudinal tracking capabilities.
Imbio PHA (4.0.0) generates annotated DICOM images and provides summary reports in PDF format. Rapid Aortic Measurements offers automated 3D image reconstructions of the entire aorta and provides 2D and 3D visualizations of segmented vessels.
Imbio PHA (4.0.0) integrates with native DICOM tools and workflows. Rapid Aortic Measurements is integrated into the Rapid Enterpriseu2122 Platform.